Molecular mechanisms of pain regulation in patients with osteoarthritis

Molecular mechanisms of pain regulation in patients with osteoarthritis

Objective: to study the mechanisms determining the level of pain on the basis of an analysis of the expression profiles of the genes involved in joint destruction, inflammation, and metabolic regulation in the blood of patients with osteoarthritis (OA) with different expression levels of the Mammali...

Full description

Bibliographic Details
Main Authors:	E. V. Chetina, G. A. Markova, E. A. Taskina, E. P. Sharapova, N. G. Kashevarova, L. I. Alekseeva, V. V. Kolomatsky, M. A. Makarov, A. L. Logunov, S. A. Makarov, A. N. Kuzin
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2016-10-01
Series:	Научно-практическая ревматология
Subjects:	osteoarthritis pain gene expression blood mtor mmp9 timp1
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2272

Similar Items

FUNCTIONS OF THE mTOR SIGNALING PATHWAY IN NORMAL ARTICULAR CARTILAGE CHONDROCYTES AND IN OSTEOARTHRITIS
by: E. V. Chetina, et al.
Published: (2016-12-01)

Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2
by: V. O. Shavrin, et al.
Published: (2020-08-01)

SERUM CONCENTRATIONS OF MATRIX METALLOPROTEINASE-9, -13 AND TIMP-1 IN AN OVARIECTOMIZED WISTAR RAT MODEL OF OSTEOPOROSIS
by: Armine V. Grigoryan, et al.
Published: (2017-12-01)

Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2015-12-01)

LONG-TERM TREATMENT RESULTS OF BONE SARCOMA PATIENTS WITH CONSIDERATION OF SERUM METALLOPROTEINASE LEVELS
by: I. V. Babkina, et al.
Published: (2016-02-01)

Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report
by: Arleta Waszczykowska, et al.
Published: (2020-11-01)

MOLECULAR MECHANISMS OF INHIBITION OF COLLAGEN CLEAVAGE ACTIVITY BY DEFEROXAMINE IN THE CARTILAGE OF PATIENTS WITH OSTEOARTHRITIS
by: E. V. Chetina, et al.
Published: (2017-03-01)

CD8+ T Cell-Induced Expression of Tissue Inhibitor of Metalloproteinses-1 Exacerbated Osteoarthritis
by: Po-Chuan Shen, et al.
Published: (2013-10-01)

Changes in Gene and Protein Expression of Metalloproteinase-2 and -9 and their Inhibitors TIMP2 and TIMP3 in Different Parts of Fluoride-Exposed Rat Brain
by: Agnieszka Łukomska, et al.
Published: (2021-12-01)

Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction
by: Lu X, et al.
Published: (2016-07-01)

Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood
by: Tita Husnitawati Madjid, et al.
Published: (2020-06-01)

Differential Spatio-Temporal Regulation of MMPs in the 5xFAD Mouse Model of Alzheimer’s disease: Evidence for aPro-Amyloidogenic Role of MT1-MMP
by: Nathalie ePy, et al.
Published: (2014-09-01)

Expression of genes related to glucose metabolism and joint destruction in the development of diabetes mellitus in patients with osteoarthritis
by: E. V. Chetina, et al.
Published: (2019-03-01)

Interplay between matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in acute asthma exacerbation and airway remodeling
by: Ghada Mahmoud Mohamed, et al.
Published: (2012-07-01)

Study of the level of sputum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor metalloproteinase-1 (TIMP-1) in COPD patients
by: Sherif A. Esa, et al.
Published: (2014-10-01)

Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure
by: Nissi Ritva, et al.
Published: (2013-01-01)

THE VALUES OF MATRIX METALLOPROTEASE-9 AND TISSUE METALLOPROTEASE INHIBITOR-1 IN ACUTE MYOCARDIAL INFARCTION WITH ANEURYSM FORMATION
by: A. V. Govorin, et al.
Published: (2014-07-01)

Expression of matrix metalloproteinases (MMP-1, MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in oral submucous fibrosis
by: Rajendran R, et al.
Published: (2006-01-01)

Enhanced regulatory gene expressions in the blood and articular cartilage of patients with rheumatoid arthritis
by: Elena Vasilyevna Chetina, et al.
Published: (2012-08-01)

Effects of sodium hyaluronate on experimental osteoarthritis in rabbit knee joints
by: Han, Fei, et al.
Published: (1999)

PREDICTION OF THE COURSE OF OSTEOARTHROSIS FROM mTOR (MAMMALIAN TARGET OF RAPAMYCIN) GENE EXPRESSION
by: E V Chetina, et al.
Published: (2012-02-01)

The place of nonsteroidal anti-inflammatory drugs in the current osteoarthritis guidelines
by: E. A. Taskina, et al.
Published: (2020-05-01)

Fengbaisan suppresses endoplasmic reticulum stress by up-regulating SIRT1 expression to protect rats with chronic obstructive pulmonary diseases
by: Yu Wang, et al.
Published: (2020-01-01)

TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9
by: Weimin Wang, et al.
Published: (2019-01-01)

MMP8, MMP9 AND TIMP1 LEVELS IN GCF AND GINGIVAL TISSUE OF PATIENTS WITH GINGIVAL OVERGROWTH DURING ORTHODONTIC TREATMENT
by: Petra Surlin, et al.
Published: (2012-03-01)

Matrix metalloproteinase-2, -9, and tissue inhibitor of MMP-2 gene polymorphisms in Taiwanese periodontitis patients
by: Yu-Feng Hsiao, et al.
Published: (2016-12-01)

Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01)

A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
by: A. A. Ostanin, et al.
Published: (2014-07-01)

EVALUATION OF THE EFFICACY AND SAFETY OF A GLYCOSAMINOGLYCAN-PEPTIDE COMPLEX IN THE TREATMENT OF KNEE OSTEOARTHRITIS IN PATIENTS WITH PREVIOUS INEFFICIENCY OF SLOW-RELEASE ORAL ANTI-INFLAMMATORY DRUGS (THE MULTICENTER OPEN-LABEL STUDY PRIMULA: USE OF RUMALON® WITH INITIALLY SMALL SUCCESS IN THE TREATMENT OF OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2018-03-01)

The role of noninvasive methods in assessing airway inflammation and structural changes in asthma and COPD
by: K. Ahmad Dar, et al.
Published: (2015-12-01)

Elevated expression of MMP8 and MMP9 contributes to diabetic osteoarthritis progression in a rat model
by: Simin Luo, et al.
Published: (2021-01-01)

Βιολογικές δράσεις ενός συνθετικού πεπτιδίου του αυξητικού παράγοντα HARP
by: Καψάλη, Αναστασία
Published: (2011)

APPLICATION IMMUNOHISTOCHEMICALLY RESEARCH METHODS IN THE DIAGNOSIS OF PROSTATE CANCER
by: S. A. Pulbere, et al.
Published: (2017-10-01)

The Anti-inflammatory and Anti-apoptotic Role of Crocin against Expression of MMp-9, TIMP-1, MCP-1, Caspase-3, PPARα in Heart Tissue, and Metamorphoses of MicroRNA 188 in Hyperhomocysteinemic Rats
by: Samy A. Hussein, et al.
Published: (2019-09-01)

Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer
by: Camilla Böckelman, et al.
Published: (2018-06-01)

Exendin-4 Alleviates High Glucose-Induced Rat Mesangial Cell Dysfunction through the AMPK Pathway
by: Wen-Wei Xu, et al.
Published: (2014-02-01)

THE ROLE OF MATRIX METALLOPROTEINASE MMP-9, ITS INHIBITOR TIMP-1 AND INTERLEUKINE-1β IN PATHOGENESIS OF TRAUMATIC BRAIN INJURY
by: S. V. Ziablitsev, et al.
Published: (2016-09-01)

TIMP way to stop metastasis?
by: Katarzyna Jarosz, et al.
Published: (2017-08-01)

Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
by: Yixuan Gong, et al.
Published: (2014-06-01)

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer
by: Renato F. Ivanovic, et al.
Published: (2018-10-01)

Cannot write session to /tmp/vufind_sessions/sess_rgugj3eb432e0h2tsao5s8lbip